Jump to main content
Jump to site search

Issue 3, 2018
Previous Article Next Article

Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

Author affiliations

Abstract

In this study, the (S)-enantiomers of the aporphine alkaloids, nuciferine and roemerine, were prepared via a synthetic route involving catalytic asymmetric hydrogenation and both stereoisomers were evaluated in vitro for functional activity at human 5-HT2 and adrenergic α1 receptor subtypes using a transforming growth factor-α shedding assay. Both enantiomers of each of the compounds were found to act as antagonists at 5-HT2 and α1 receptors. (R)-roemerine was the most potent compound at 5-HT2A and 5-HT2C receptors (pKb = 7.8–7.9) with good selectivity compared to (S)-roemerine at these two receptors and compared to its activity at 5-HT2B, α1A, α1B and α1D receptors.

Graphical abstract: Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 Dec 2017, accepted on 09 Feb 2018 and first published on 26 Feb 2018


Article type: Research Article
DOI: 10.1039/C7MD00629B
Citation: Med. Chem. Commun., 2018,9, 576-582
  •   Request permissions

    Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

    H. L. Heng, C. F. Chee, S. P. Chin, Y. Ouyang, H. Wang, M. J. C. Buckle, D. R. Herr, I. C. Paterson, S. W. Doughty, N. Abd. Rahman and L. Y. Chung, Med. Chem. Commun., 2018, 9, 576
    DOI: 10.1039/C7MD00629B

Search articles by author

Spotlight

Advertisements